Description

Sarcosine Powder

Sarcosine
CAS Number	107-97-1
Molar Mass	89.093 g/mol-1
Chemical Formula	C3H7NO2
IUPAC Name	N-methylglycine

Introduction

Sarcosine, also known as N-methylglycine, is a naturally occurring amino acid derivative. In its pure powdered form, it has garnered attention in research for its potential impact on various aspects of neurological and psychological health.

Key Characteristics

Sarcosine is characterized by its role as an intermediate in the metabolism of glycine and methionine. It acts as a substrate for glycine transport and metabolism, influencing neurotransmitter systems in the brain.

Research Applications

Sarcosine has been investigated for its potential applications in neuroscience and mental health research. Its modulatory effects on neurotransmitters make it a subject of interest in studies exploring cognitive functions, mental disorders, and emotional well-being.

Research Benefits

Sarcosine on Brain Health, Memory, and Learning

Research suggests that sarcosine may impact cognitive functions, including memory and learning. Studies have explored its potential neuroprotective effects and its role in enhancing synaptic plasticity, contributing to improved cognitive performance.

Sarcosine and Schizophrenia

There is evidence indicating that sarcosine may have therapeutic implications for schizophrenia. Studies have investigated its role in modulating glutamatergic transmission, potentially mitigating symptoms associated with this mental health disorder.

Sarcosine and Anxiety

Some research suggests that sarcosine may influence anxiety-related behaviors. Studies have explored its anxiolytic effects, pointing towards its potential role in the regulation of emotional states.

Summary

In summary, Sarcosine Powder, as a subject of scientific investigation, holds promise in areas related to brain health, cognitive function, schizophrenia, and anxiety. Its unique characteristics make it a valuable compound for further exploration in the realm of neuroscience and mental health research.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Burgdorf J, Zhang XL, Weiss C, Matthews E, Disterhoft JF, Stanton PK, Moskal JR. The N-methyl-D-aspartate receptor modulator GLYX-13 enhances learning and memory, in young adult and learning impaired aging rats. Neurobiol Aging. 2011 Apr;32(4):698-706. doi: 10.1016/j.neurobiolaging.2009.04.012. Epub 2009 May 14. PMID: 19446371; PMCID: PMC3035742. [Read More].
2. Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri C, Okada S, Hasegawa H, Imai K, Iyo M. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry. 2003 Jun;60(6):572-6. doi: 10.1001/archpsyc.60.6.572. PMID: 12796220. [Read More].
3. Komatsu H, Furuya Y, Sawada K, Asada T. Involvement of the strychnine-sensitive glycine receptor in the anxiolytic effects of GlyT1 inhibitors on maternal separation-induced ultrasonic vocalization in rat pups. Eur J Pharmacol. 2015 Jan 5;746:252-7. doi: 10.1016/j.ejphar.2014.11.024. Epub 2014 Nov 27. PMID: 25435080. [Read More].